Actual biological diagnosis of acute myeloblastic leukemia in children

Abstract Acute myeloblastic leukemia accounts for approximately 20% of acute leukemias in children. The days the microscope represented the main tool in the diagnosis and classification of Acute Myeloblastic Leukemia seem to be very far. This review summarizes the current diagnosis of this malignanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Buga Corbu, V, Glűck, A, Arion, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2014
Materias:
Young Researchers Area
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197485/
https://www.ncbi.nlm.nih.gov/pubmed/25408742
_version_ 1782339633942626304
author Buga Corbu, V
Glűck, A
Arion, C
author_facet Buga Corbu, V
Glűck, A
Arion, C
author_sort Buga Corbu, V
collection PubMed
description Abstract Acute myeloblastic leukemia accounts for approximately 20% of acute leukemias in children. The days the microscope represented the main tool in the diagnosis and classification of Acute Myeloblastic Leukemia seem to be very far. This review summarizes the current diagnosis of this malignancy, where the morphological, cytochemical, immunophenotyping, cytogenetic and molecular characterization represents the basement of a risk group related therapy.
format Online
Article
Text
id pubmed-4197485
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Carol Davila University Press
record_format MEDLINE/PubMed
spelling pubmed-41974852014-11-18 Actual biological diagnosis of acute myeloblastic leukemia in children Buga Corbu, V Glűck, A Arion, C J Med Life Young Researchers Area Abstract Acute myeloblastic leukemia accounts for approximately 20% of acute leukemias in children. The days the microscope represented the main tool in the diagnosis and classification of Acute Myeloblastic Leukemia seem to be very far. This review summarizes the current diagnosis of this malignancy, where the morphological, cytochemical, immunophenotyping, cytogenetic and molecular characterization represents the basement of a risk group related therapy. Carol Davila University Press 2014-06-15 2014-06-25 /pmc/articles/PMC4197485/ /pubmed/25408742 Text en ©Carol Davila University Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Young Researchers Area
Buga Corbu, V
Glűck, A
Arion, C
Actual biological diagnosis of acute myeloblastic leukemia in children
title Actual biological diagnosis of acute myeloblastic leukemia in children
title_full Actual biological diagnosis of acute myeloblastic leukemia in children
title_fullStr Actual biological diagnosis of acute myeloblastic leukemia in children
title_full_unstemmed Actual biological diagnosis of acute myeloblastic leukemia in children
title_short Actual biological diagnosis of acute myeloblastic leukemia in children
title_sort actual biological diagnosis of acute myeloblastic leukemia in children
topic Young Researchers Area
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197485/
https://www.ncbi.nlm.nih.gov/pubmed/25408742
work_keys_str_mv AT bugacorbuv actualbiologicaldiagnosisofacutemyeloblasticleukemiainchildren
AT glucka actualbiologicaldiagnosisofacutemyeloblasticleukemiainchildren
AT arionc actualbiologicaldiagnosisofacutemyeloblasticleukemiainchildren

Ejemplares similares